These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3607969)

  • 1. Modification of the polar head group of platelet-activating factor: influence on the biological activity.
    Ostermann G; Kertscher HP; Lang A; Till U
    Chem Phys Lipids; 1987 May; 43(4):247-55. PubMed ID: 3607969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group.
    Wissner A; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1365-7. PubMed ID: 4032438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
    Hofmann B; Ostermann G; Kertscher HP; Till U
    Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1986 Mar; 29(3):328-33. PubMed ID: 3950913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1181-7. PubMed ID: 4032422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
    Kertscher HP; Ostermann G
    Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
    Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
    J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical synthesis and physiological activity of sulfonium analogues of platelet activating factor.
    Kates M; Adams GA; Blank ML; Snyder F
    Lipids; 1991 Dec; 26(12):1095-101. PubMed ID: 1819693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and biologic activity of some stable structure analogs of platelet activating factor].
    Kertscher HP; Ostermann G; Lang A; Weissflog W; Gawrisch K
    Pharmazie; 1985 Oct; 40(10):702-4. PubMed ID: 4080785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
    Steiner M; Landolfi R; Motola NC; Turcotte JG
    Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.
    Polonsky J; Tencé M; Varenne P; Das BC; Lunel J; Benveniste J
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7019-23. PubMed ID: 6938950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
    Stewart AG; Grigoriadis G
    J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antagonists of platelet activating factor].
    Tokumura A; Tsukatani H
    Seikagaku; 1985 Dec; 57(12):1618-23. PubMed ID: 3009656
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
    Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.
    Wissner A; Carroll ML; Green KE; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Wrenn S; Kohler CA
    J Med Chem; 1992 May; 35(9):1650-62. PubMed ID: 1578493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain.
    Wissner A; Sum PE; Schaub RE; Kohler CA; Goldstein BM
    J Med Chem; 1984 Sep; 27(9):1174-81. PubMed ID: 6471071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.
    Tokumura A; Yoshida J; Maruyama T; Fukuzawa K; Tsukatani H
    Thromb Res; 1987 Apr; 46(1):51-63. PubMed ID: 3647677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets].
    Rotllan E; Escolar G; Ordinas A; Bastida E
    Sangre (Barc); 1993 Apr; 38(2):115-9. PubMed ID: 8390724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.